Search results
Results From The WOW.Com Content Network
Neuron is a biweekly peer-reviewed scientific journal published by Cell Press, an imprint of Elsevier. Established in 1988, it covers neuroscience and related biological processes. The current editor-in-chief is Mariela Zirlinger. The founding editors were Lily Jan, A. James Hudspeth, Louis Reichardt, Roger Nicoll, and Zach Hall.
A number of online neuroscience databases are available which provide information regarding gene expression, neurons, macroscopic brain structure, and neurological or psychiatric disorders. Some databases contain descriptive and numerical data, some to brain function, others offer access to 'raw' imaging data, such as postmortem brain sections ...
Cell Press published its first open access journal, Cell Reports, in 2012. [3] In January 2021, all Cell Press journals began offering open access publishing options. [4] As of May 2022, Cell Press publishes 17 open access journals and 40 hybrid journals. In 2021, 50% of all articles published in Cell Press were open access. [5]
This is a list of open-access journals by field. The list contains notable journals which have a policy of full open access.
Experts explain the best time of day to go on a walk, depending on your goals from weight loss to digestion. There are benefits for morning, afternoon, and evening walks.
The journal was established in 1988 and is published by Elsevier. [1] It covers all aspects of research on artificial neural networks. The founding editor-in-chief was Stephen Grossberg (Boston University). The current editors-in-chief are DeLiang Wang (Ohio State University) and Taro Toyoizumi (RIKEN Center for Brain Science).
Intel said on Wednesday its deal for $7.86 billion in U.S. government subsidies restricts the company's ability to sell stakes in its chipmaking unit if it becomes an independent entity. The U.S ...
Karyn Hascal, The Healing Place’s president and CEO, said she would never allow Suboxone in her treatment program because her 12-step curriculum is “a drug-free model. There’s kind of a conflict between drug-free and Suboxone.” For policymakers, denying addicts the best scientifically proven treatment carries no political cost.